Infinity Natural Resources, Inc.
INR NYSE Crude Petroleum & Natural Gas Financials FY2023βFY2025
What Infinity Natural Resources, Inc. does
No business description yet.
- Legal name
- INFINITY NATURAL RESOURCES, INC.
- Fiscal year ends
- December 31, 2025
- Latest annual report
- 10-K Β· Mar 10, 2026
- Accession Β· CIK
- 0002029118-26-000014
0002029118
Revenue and margins
Infinity Natural Resources, Inc. had $356M of revenue in fiscal 2025, up 37.6% on the year before.
Net income and earnings per share
Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was β in fiscal 2025, β of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Infinity Natural Resources, Inc. returned β to shareholders in fiscal 2025. The diluted share count rose 0.0%.
Balance sheet
Cash, debt and the ratios that show how comfortably Infinity Natural Resources, Inc. can carry it.
| Fiscal year end | FY23 | FY24 | FY25 |
|---|---|---|---|
| Cash and short-term investments | $1.5M | $2.2M | $2.8M |
| Debt incl. finance leases | β | $260M | $0.1M |
| Net debt / EBITDA | β | 1.5x | β0.0x |
| Debt / equity | β | β | 0.0x |
| Current ratio | β | 0.6x | 1.6x |
| Quick ratio | β | 0.6x | 1.6x |
| Total assets | β | $915M | $1.2B |
| Total liabilities | β | $407M | $263M |
| Shareholders' equity | β | $0.0M | $307M |
| Net debt (β = net cash) | β | $257M | β$2.8M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$0.0M
0 insiders
Of sales under plans
β
$0.0M
No open-market insider trades in the last 12 months.
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | β / 3 | β / 4 | 7 / 8 |
| Accruals ratio | β | β19.4% | β23.0% |
| Altman Z'' | β | 0.35 | 1.59 |
3 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY23 | FY24 | FY25 |
|---|---|---|---|
| Income statement | |||
| Revenue | $162M | $259M | $356M |
| Operating income | $52.7M | $93.7M | $11.9M |
| Pretax income | $86.7M | $49.3M | $59.1M |
| Income tax | $0.0M | $0.0M | β$4.9M |
| Net income | $86.7M | $0.0M | $13.8M |
| Diluted EPS | $0.00 | $0.00 | $0.89 |
| Diluted shares | 0.00B | 0.00B | 0.06B |
| Cash flow | |||
| Cash from operations | $106M | $178M | $262M |
| Depreciation and amortization | $53.8M | $73.7M | $104M |
| Stock-based compensation | $0.0M | $0.0M | $133M |
| Balance sheet | |||
| Cash and short-term investments | $1.5M | $2.2M | $2.8M |
| Total debt | β | $260M | $0.1M |
| Current assets | β | $85.6M | $161M |
| Current liabilities | β | $133M | $103M |
| Total assets | β | $915M | $1.2B |
| Total liabilities | β | $407M | $263M |
| Shareholders' equity | β | $0.0M | $307M |
| Margins | |||
| Operating margin | 32.6% | 36.2% | 3.3% |
| EBITDA margin | 65.8% | 64.7% | 32.4% |
| Net margin | 53.6% | 0.0% | 3.9% |
| Returns | |||
| Return on capital | β | 36.4% | 3.9% |
| Return on capital employed | β | 12.0% | 1.0% |
| Return on equity | β | β | 9.0% |
| Return on assets | β | 0.0% | 1.3% |
| Return on tangible equity | β | β | 4.5% |
| Growth | |||
| Revenue growth | β | 60.2% | 37.6% |
| Net income growth | β | β100.0% | β |
| Financial health | |||
| Net debt / EBITDA | β | 1.5x | β0.0x |
| Debt / equity | β | β | 0.0x |
| Current ratio | β | 0.6x | 1.6x |
| Quick ratio | β | 0.6x | 1.6x |
| Capital allocation | |||
| Stock comp / revenue | 0.0% | 0.0% | 37.4% |
| Quality scores | |||
| Piotroski F-score | β | β | 7.0 |
| Altman Z'' | β | 0.3 | 1.6 |
| Accruals ratio | β | β19.4% | β23.0% |
Source: SEC EDGAR XBRL filings (CIK 0002029118). Data updated October 24, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.